Karolinska Development raises Skr378m via rights issue
Shareholders subscribed for 77% of the new shares on offer in Nordic life science investment company's rights offer
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts